Clinical Trial Update: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase III randomized trial evaluating ENIA11 in combination with DMARDs versus DMARDs alone in rheumatoid arthritis; the study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENIA11

Snippet

Sponsor: Mycenax Biotech Inc. | Conditions: Combination With DMARDs | Phase 3 | Status: UNKNOWN